Literature DB >> 16871082

Systemic thromboses after cardiopulmonary bypass: is it thrombin or antithrombin?

Kenichi A Tanaka, Roman Sniecinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16871082     DOI： 10.1097/00000542-200608000-00030

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  4 in total

Review 1.  Antifibrinolytic therapy: evidence, bias, confounding (and politics!).

Authors:  Paul Myles
Journal:  J Extra Corpor Technol       Date:  2007-12

2.  Accelerated Intravascular Activation of Coagulation During Cardiopulmonary Bypass.

Authors:  Satyen Parida; Pranit Patil; Sreevathsa K S Prasad; Ajay Kumar Jha; Sakthirajan Panneerselvam
Journal:  Indian J Hematol Blood Transfus       Date:  2020-02-24       Impact factor: 0.900

Review 3.  Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery.

Authors:  Masahiro Ide; Daniel Bolliger; Taro Taketomi; Kenichi A Tanaka
Journal:  J Anesth       Date:  2009-12-29       Impact factor: 2.078

4.  Disseminated intravascular and intracardiac thrombosis after cardiopulmonary bypass.

Authors:  Deepak K Tempe; Parin Lalwani; Kapil Chaudhary; Harpreet S Minas; Akhlesh S Tomar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.